ABSTRACT

One drop of bimatoprost 0.03%, given once daily in eyes with high IOP, facilitated a target IOP ≤ 18 mm Hg in 69.2-78% of the treated population.7-10 Therefore, a monotherapy with bimatoprost is likely to be an effective schedule in the majority of eyes affected by ocular hypertension.